Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea
· Delayed Price · Currency is KRW 5,080.00
+40.00 (0.79%)
At close: Dec 5, 2025
Meta Biomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 137,480 | 84,852 | 99,718 | 52,832 | 66,184 | 64,352 | Upgrade
|
| Market Cap Growth | 48.42% | -14.91% | 88.74% | -20.17% | 2.85% | -0.69% | Upgrade
|
| Enterprise Value | 139,383 | 95,997 | 130,453 | 76,546 | 89,589 | 96,285 | Upgrade
|
| Last Close Price | 5080.00 | 3710.00 | 4324.16 | 2280.03 | 2828.33 | 2729.28 | Upgrade
|
| PE Ratio | 8.25 | 3.79 | 9.89 | 20.11 | 6.95 | - | Upgrade
|
| PS Ratio | 1.38 | 0.90 | 1.20 | 0.77 | 1.13 | 1.43 | Upgrade
|
| PB Ratio | 1.13 | 0.88 | 1.37 | 0.83 | 1.10 | 1.30 | Upgrade
|
| P/TBV Ratio | 1.17 | 0.93 | 1.46 | 0.91 | 1.16 | 1.38 | Upgrade
|
| P/FCF Ratio | 36.08 | 7.24 | - | - | 7.30 | 24.43 | Upgrade
|
| P/OCF Ratio | 7.93 | 3.75 | 9.76 | 5.77 | 5.94 | 13.24 | Upgrade
|
| EV/Sales Ratio | 1.40 | 1.02 | 1.57 | 1.11 | 1.52 | 2.14 | Upgrade
|
| EV/EBITDA Ratio | 4.76 | 4.32 | 8.80 | 8.30 | 10.14 | 14.92 | Upgrade
|
| EV/EBIT Ratio | 5.84 | 5.57 | 12.30 | 14.27 | 17.03 | 38.30 | Upgrade
|
| EV/FCF Ratio | 36.58 | 8.19 | - | - | 9.88 | 36.55 | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.58 | 0.61 | 0.70 | 0.57 | 1.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.53 | 2.53 | 3.00 | 4.78 | 3.90 | 7.73 | Upgrade
|
| Debt / FCF Ratio | 11.52 | 4.79 | - | - | 3.80 | 18.95 | Upgrade
|
| Asset Turnover | 0.57 | 0.61 | 0.66 | 0.62 | 0.56 | 0.43 | Upgrade
|
| Inventory Turnover | 2.41 | 2.73 | 2.99 | 2.65 | 2.10 | 1.58 | Upgrade
|
| Quick Ratio | 1.07 | 0.94 | 0.71 | 0.75 | 0.76 | 0.70 | Upgrade
|
| Current Ratio | 1.55 | 1.28 | 1.12 | 1.14 | 1.20 | 1.10 | Upgrade
|
| Return on Equity (ROE) | 17.64% | 26.25% | 14.74% | 4.61% | 17.37% | -5.92% | Upgrade
|
| Return on Assets (ROA) | 8.33% | 7.00% | 5.28% | 2.99% | 3.12% | 1.49% | Upgrade
|
| Return on Capital (ROIC) | 9.45% | 7.99% | 5.90% | 3.32% | 3.39% | 1.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.90% | 16.60% | 12.40% | 7.00% | 8.10% | 4.20% | Upgrade
|
| Earnings Yield | 13.37% | 26.40% | 10.11% | 4.97% | 14.39% | -6.36% | Upgrade
|
| FCF Yield | 2.77% | 13.81% | -1.27% | -11.80% | 13.70% | 4.09% | Upgrade
|
| Dividend Yield | 0.60% | 0.81% | 0.46% | 0.88% | 0.71% | 0.37% | Upgrade
|
| Payout Ratio | 1.80% | 2.04% | 4.54% | 17.43% | 2.40% | - | Upgrade
|
| Buyback Yield / Dilution | 37.61% | -18.55% | 0.06% | 0.07% | 0.61% | 1.08% | Upgrade
|
| Total Shareholder Return | 38.20% | -17.74% | 0.53% | 0.95% | 1.31% | 1.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.